Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Sleep ended up being the biggest predictor of having a cardiovascular disease event and dying from any cause. The underlying ...

This new AI heart disease detector can’t be beat. S (SHD) refers to defects in the heart’s valves, wall or chambers that are present at birth or develop ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Better prevention and emergency cardiovascular care have dramatically reduced heart attack deaths, but other heart conditions like heart failure and arrhythmias are claiming more lives.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...